Better Context → Better Decisions
Context counts in life sciences. The FENIX analyst team is tirelessly using its experience to put you in a position to succeed. Below, our readers with corporate access will find a wealth of contextualized life science insight ready to be viewed in the FENIX Marketplace.
Welcome to FENIX Syndicated Services. If you already have an account, please log in. If you have any questions or would like to subscribe to our services, please contact us.
$599
Posted in: Basal Insulin, Bolus Insulin, DPP-IVi, Dual/triple agonist, GLP-1RA, Glucagon, Other, SGLT2i, Topics Sep 14 | 2018New Lilly Academic Collaboration to Help Compete with Novo/OxfordPurchase Blast
$599
Posted in: SGLT2i, Topics Sep 13 | 2018CREDENCE and CANVAS Filing Update & ImplicationsPurchase Blast
$599
Posted in: Basal Insulin, Bolus Insulin, Dual/triple agonist, GLP-1RA, GLP-1RA + Basal, Glucagon, Insulin Delivery, Other, SGLT2i, Topics Sep 13 | 2018Sanofi Restructures GBUs; Stefan Oelrich Moves to BayerPurchase Blast
$599
Posted in: Glucose Monitoring, Topics Sep 12 | 2018One Drop Now Integrates with Apple WatchPurchase Blast
$599
Posted in: GLP-1RA, Topics Sep 12 | 2018Semaglutide Ph2 NASH Study Completes EnrollmentPurchase Blast
$599
Posted in: Glucose Monitoring, Topics Sep 12 | 2018Thoughts on New Non-Invasive CGM DataPurchase Blast
$599
Posted in: Glucagon, Topics Sep 10 | 2018Zealand Lixi Royalty Sale May Indicate BD ChallengesPurchase Blast
$599
Posted in: Basal Insulin, Bolus Insulin, Glucose Monitoring, Insulin Delivery, Other, Topics Sep 05 | 2018Livongo-Abbott Integration with Libre ProPurchase Blast$599
Posted in: Bolus Insulin, Other, Topics Sep 05 | 2018MannKind Partners for Pulmonary Hypertension; $MNKD up ~100%Purchase Blast$599
Posted in: Basal Insulin, Bolus Insulin, Insulin Delivery, Other, Topics Sep 04 | 2018Sanofi DCV CMO LeavesPurchase Blast
$599
Posted in: Dual/triple agonist, GLP-1RA, Other, Topics Sep 04 | 2018Novo Partners for Cross BBB Drug DeliveryPurchase Blast
$599
Posted in: DPP-IVi, SGLT2i, Topics Aug 30 | 2018FENIX Analysis: Triplet SGLT2i+DPP-IVi+MET FDCsPurchase Blast
$599
Posted in: SGLT2i, Topics Aug 30 | 2018New FDA SGLT2i Warning For Rare Genital InfectionsPurchase Blast
$599
Posted in: Glucose Monitoring, Topics Aug 29 | 2018Senseonics Partners with Beyond Type 1 for Patient Awareness/EducationPurchase Blast
$599
Posted in: Basal Insulin, DPP-IVi, Other, SGLT2i, Topics Aug 29 | 2018Thoughts on Merck's Digital Diabetes AppPurchase Blast
$599
Posted in: Glucose Monitoring, Insulin Delivery, Topics Aug 28 | 2018Medtronic Guardian Sensor 3 CGM Now Integrated with 630GPurchase Blast
$599
Posted in: SGLT2i, Topics Aug 28 | 2018UPDATED FENIX Analysis: SGLT2i HF CVOTs and Stopping Early ScenariosPurchase Blast